Fitbit Receives FDA Approval for a Wearable Device App That Detects Atrial Fibrillation

Many companies want to adapt consumer wearables to monitor health conditions, including biomarkers tested by medical laboratories Clinical laboratory managers know that wearable devices for monitoring biophysical functions or measuring biomarkers are becoming more complex and capable thanks to advances in miniaturization, informatics, software, and artificial intelligence machine learning that enable new functions to be developed and proved to be accurate. In September, Fitbit (NYSE:FIT), took...
;